nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefloquine—HBA2—type 2 diabetes mellitus	0.29	0.574	CbGaD
Mefloquine—HBA1—type 2 diabetes mellitus	0.196	0.388	CbGaD
Mefloquine—BCHE—Ramipril—type 2 diabetes mellitus	0.0415	0.173	CbGbCtD
Mefloquine—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0206	0.086	CbGbCtD
Mefloquine—CYP3A4—type 2 diabetes mellitus	0.0194	0.0385	CbGaD
Mefloquine—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0184	0.0767	CbGbCtD
Mefloquine—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0133	0.0554	CbGbCtD
Mefloquine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0125	0.0522	CbGbCtD
Mefloquine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0123	0.0515	CbGbCtD
Mefloquine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0115	0.0482	CbGbCtD
Mefloquine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.011	0.0459	CbGbCtD
Mefloquine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0101	0.042	CbGbCtD
Mefloquine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00948	0.0396	CbGbCtD
Mefloquine—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00912	0.0381	CbGbCtD
Mefloquine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00909	0.0379	CbGbCtD
Mefloquine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00879	0.0367	CbGbCtD
Mefloquine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00795	0.0332	CbGbCtD
Mefloquine—ABCB1—Glyburide—type 2 diabetes mellitus	0.0068	0.0284	CbGbCtD
Mefloquine—ABCB1—Losartan—type 2 diabetes mellitus	0.00622	0.0259	CbGbCtD
Mefloquine—HBA2—leg—type 2 diabetes mellitus	0.0061	0.138	CbGeAlD
Mefloquine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00603	0.0252	CbGbCtD
Mefloquine—HBA1—hindlimb—type 2 diabetes mellitus	0.00593	0.135	CbGeAlD
Mefloquine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00578	0.0241	CbGbCtD
Mefloquine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00578	0.0241	CbGbCtD
Mefloquine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00546	0.0228	CbGbCtD
Mefloquine—HBA2—hindlimb—type 2 diabetes mellitus	0.00545	0.124	CbGeAlD
Mefloquine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00407	0.017	CbGbCtD
Mefloquine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00372	0.0155	CbGbCtD
Mefloquine—HBA2—artery—type 2 diabetes mellitus	0.00334	0.0758	CbGeAlD
Mefloquine—HBA2—endothelium—type 2 diabetes mellitus	0.00282	0.064	CbGeAlD
Mefloquine—ADORA1—nerve—type 2 diabetes mellitus	0.00149	0.0338	CbGeAlD
Mefloquine—HBA2—retina—type 2 diabetes mellitus	0.00137	0.0311	CbGeAlD
Mefloquine—HBA1—cardiovascular system—type 2 diabetes mellitus	0.00126	0.0287	CbGeAlD
Mefloquine—HBA1—kidney—type 2 diabetes mellitus	0.00124	0.0281	CbGeAlD
Mefloquine—HBA1—pancreas—type 2 diabetes mellitus	0.00123	0.0279	CbGeAlD
Mefloquine—HBA2—cardiovascular system—type 2 diabetes mellitus	0.00116	0.0263	CbGeAlD
Mefloquine—HBA2—kidney—type 2 diabetes mellitus	0.00114	0.0258	CbGeAlD
Mefloquine—HBA2—pancreas—type 2 diabetes mellitus	0.00113	0.0256	CbGeAlD
Mefloquine—HBA1—adipose tissue—type 2 diabetes mellitus	0.00111	0.0253	CbGeAlD
Mefloquine—HBA2—adipose tissue—type 2 diabetes mellitus	0.00102	0.0232	CbGeAlD
Mefloquine—HBA1—liver—type 2 diabetes mellitus	0.000782	0.0177	CbGeAlD
Mefloquine—HBA2—liver—type 2 diabetes mellitus	0.000718	0.0163	CbGeAlD
Mefloquine—ACHE—islet of Langerhans—type 2 diabetes mellitus	0.000717	0.0163	CbGeAlD
Mefloquine—ADORA2A—cardiovascular system—type 2 diabetes mellitus	0.000604	0.0137	CbGeAlD
Mefloquine—ADORA1—cardiovascular system—type 2 diabetes mellitus	0.000522	0.0118	CbGeAlD
Mefloquine—ADORA1—kidney—type 2 diabetes mellitus	0.00051	0.0116	CbGeAlD
Mefloquine—ADORA1—cortex of kidney—type 2 diabetes mellitus	0.000497	0.0113	CbGeAlD
Mefloquine—ADORA1—adipose tissue—type 2 diabetes mellitus	0.00046	0.0104	CbGeAlD
Mefloquine—ADORA2A—liver—type 2 diabetes mellitus	0.000374	0.00848	CbGeAlD
Mefloquine—CYP19A1—adipose tissue—type 2 diabetes mellitus	0.000312	0.00708	CbGeAlD
Mefloquine—BCHE—nephron tubule—type 2 diabetes mellitus	0.000284	0.00644	CbGeAlD
Mefloquine—BCHE—cardiovascular system—type 2 diabetes mellitus	0.000255	0.00578	CbGeAlD
Mefloquine—BCHE—adipose tissue—type 2 diabetes mellitus	0.000225	0.0051	CbGeAlD
Mefloquine—CYP19A1—liver—type 2 diabetes mellitus	0.000219	0.00496	CbGeAlD
Mefloquine—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000168	0.00381	CbGeAlD
Mefloquine—CYP3A4—kidney—type 2 diabetes mellitus	0.000168	0.00381	CbGeAlD
Mefloquine—CYP2D6—kidney—type 2 diabetes mellitus	0.000165	0.00375	CbGeAlD
Mefloquine—BCHE—liver—type 2 diabetes mellitus	0.000158	0.00357	CbGeAlD
Mefloquine—ABCB1—retina—type 2 diabetes mellitus	0.000144	0.00326	CbGeAlD
Mefloquine—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000135	0.00307	CbGeAlD
Mefloquine—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000121	0.00275	CbGeAlD
Mefloquine—ABCB1—kidney—type 2 diabetes mellitus	0.000119	0.0027	CbGeAlD
Mefloquine—ABCB1—pancreas—type 2 diabetes mellitus	0.000118	0.00268	CbGeAlD
Mefloquine—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000116	0.00263	CbGeAlD
Mefloquine—ABCB1—adipose tissue—type 2 diabetes mellitus	0.000107	0.00243	CbGeAlD
Mefloquine—CYP3A4—liver—type 2 diabetes mellitus	0.000106	0.00241	CbGeAlD
Mefloquine—CYP2D6—liver—type 2 diabetes mellitus	0.000104	0.00237	CbGeAlD
Mefloquine—ABCB1—liver—type 2 diabetes mellitus	7.51e-05	0.0017	CbGeAlD
Mefloquine—Erythema multiforme—Ramipril—type 2 diabetes mellitus	6.83e-05	0.000604	CcSEcCtD
Mefloquine—Headache—Glimepiride—type 2 diabetes mellitus	6.82e-05	0.000603	CcSEcCtD
Mefloquine—Ill-defined disorder—Losartan—type 2 diabetes mellitus	6.81e-05	0.000602	CcSEcCtD
Mefloquine—Headache—Sitagliptin—type 2 diabetes mellitus	6.8e-05	0.000601	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	6.75e-05	0.000596	CcSEcCtD
Mefloquine—Agitation—Losartan—type 2 diabetes mellitus	6.74e-05	0.000596	CcSEcCtD
Mefloquine—Oedema—Metformin—type 2 diabetes mellitus	6.74e-05	0.000596	CcSEcCtD
Mefloquine—Tinnitus—Ramipril—type 2 diabetes mellitus	6.74e-05	0.000596	CcSEcCtD
Mefloquine—Hypertension—Irbesartan—type 2 diabetes mellitus	6.73e-05	0.000595	CcSEcCtD
Mefloquine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	6.72e-05	0.000594	CcSEcCtD
Mefloquine—Flushing—Ramipril—type 2 diabetes mellitus	6.71e-05	0.000593	CcSEcCtD
Mefloquine—Insomnia—Valsartan—type 2 diabetes mellitus	6.7e-05	0.000592	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	6.67e-05	0.000589	CcSEcCtD
Mefloquine—Paraesthesia—Valsartan—type 2 diabetes mellitus	6.65e-05	0.000588	CcSEcCtD
Mefloquine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	6.64e-05	0.000587	CcSEcCtD
Mefloquine—Chest pain—Irbesartan—type 2 diabetes mellitus	6.64e-05	0.000587	CcSEcCtD
Mefloquine—Arthralgia—Irbesartan—type 2 diabetes mellitus	6.64e-05	0.000587	CcSEcCtD
Mefloquine—Myalgia—Irbesartan—type 2 diabetes mellitus	6.64e-05	0.000587	CcSEcCtD
Mefloquine—Shock—Metformin—type 2 diabetes mellitus	6.63e-05	0.000586	CcSEcCtD
Mefloquine—Insomnia—Orlistat—type 2 diabetes mellitus	6.62e-05	0.000585	CcSEcCtD
Mefloquine—Malaise—Losartan—type 2 diabetes mellitus	6.62e-05	0.000585	CcSEcCtD
Mefloquine—Anxiety—Irbesartan—type 2 diabetes mellitus	6.62e-05	0.000585	CcSEcCtD
Mefloquine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	6.61e-05	0.000585	CcSEcCtD
Mefloquine—Nervous system disorder—Metformin—type 2 diabetes mellitus	6.61e-05	0.000585	CcSEcCtD
Mefloquine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	6.6e-05	0.000584	CcSEcCtD
Mefloquine—Dyspnoea—Valsartan—type 2 diabetes mellitus	6.6e-05	0.000584	CcSEcCtD
Mefloquine—Vertigo—Losartan—type 2 diabetes mellitus	6.59e-05	0.000583	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	6.59e-05	0.000583	CcSEcCtD
Mefloquine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	6.59e-05	0.000583	CcSEcCtD
Mefloquine—Somnolence—Valsartan—type 2 diabetes mellitus	6.58e-05	0.000582	CcSEcCtD
Mefloquine—Syncope—Losartan—type 2 diabetes mellitus	6.58e-05	0.000582	CcSEcCtD
Mefloquine—Paraesthesia—Orlistat—type 2 diabetes mellitus	6.57e-05	0.000581	CcSEcCtD
Mefloquine—Leukopenia—Losartan—type 2 diabetes mellitus	6.57e-05	0.000581	CcSEcCtD
Mefloquine—Discomfort—Irbesartan—type 2 diabetes mellitus	6.56e-05	0.00058	CcSEcCtD
Mefloquine—Skin disorder—Metformin—type 2 diabetes mellitus	6.55e-05	0.000579	CcSEcCtD
Mefloquine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	6.52e-05	0.000576	CcSEcCtD
Mefloquine—Dyspepsia—Valsartan—type 2 diabetes mellitus	6.52e-05	0.000576	CcSEcCtD
Mefloquine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	6.51e-05	0.000576	CcSEcCtD
Mefloquine—Dizziness—Bromocriptine—type 2 diabetes mellitus	6.49e-05	0.000574	CcSEcCtD
Mefloquine—Palpitations—Losartan—type 2 diabetes mellitus	6.49e-05	0.000573	CcSEcCtD
Mefloquine—Nausea—Glimepiride—type 2 diabetes mellitus	6.47e-05	0.000571	CcSEcCtD
Mefloquine—Loss of consciousness—Losartan—type 2 diabetes mellitus	6.45e-05	0.00057	CcSEcCtD
Mefloquine—Nausea—Sitagliptin—type 2 diabetes mellitus	6.44e-05	0.00057	CcSEcCtD
Mefloquine—Dyspepsia—Orlistat—type 2 diabetes mellitus	6.44e-05	0.000569	CcSEcCtD
Mefloquine—Asthenia—Glyburide—type 2 diabetes mellitus	6.44e-05	0.000569	CcSEcCtD
Mefloquine—Decreased appetite—Valsartan—type 2 diabetes mellitus	6.44e-05	0.000569	CcSEcCtD
Mefloquine—Urticaria—Gliclazide—type 2 diabetes mellitus	6.4e-05	0.000566	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	6.39e-05	0.000565	CcSEcCtD
Mefloquine—Alopecia—Ramipril—type 2 diabetes mellitus	6.39e-05	0.000565	CcSEcCtD
Mefloquine—Fatigue—Valsartan—type 2 diabetes mellitus	6.38e-05	0.000564	CcSEcCtD
Mefloquine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	6.37e-05	0.000563	CcSEcCtD
Mefloquine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	6.37e-05	0.000563	CcSEcCtD
Mefloquine—Oedema—Irbesartan—type 2 diabetes mellitus	6.36e-05	0.000563	CcSEcCtD
Mefloquine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	6.36e-05	0.000563	CcSEcCtD
Mefloquine—Decreased appetite—Orlistat—type 2 diabetes mellitus	6.36e-05	0.000562	CcSEcCtD
Mefloquine—Pruritus—Glyburide—type 2 diabetes mellitus	6.35e-05	0.000561	CcSEcCtD
Mefloquine—Mental disorder—Ramipril—type 2 diabetes mellitus	6.33e-05	0.00056	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	6.32e-05	0.000558	CcSEcCtD
Mefloquine—Fatigue—Orlistat—type 2 diabetes mellitus	6.31e-05	0.000558	CcSEcCtD
Mefloquine—Hypotension—Metformin—type 2 diabetes mellitus	6.3e-05	0.000557	CcSEcCtD
Mefloquine—Erythema—Ramipril—type 2 diabetes mellitus	6.29e-05	0.000556	CcSEcCtD
Mefloquine—Malnutrition—Ramipril—type 2 diabetes mellitus	6.29e-05	0.000556	CcSEcCtD
Mefloquine—Shock—Irbesartan—type 2 diabetes mellitus	6.26e-05	0.000553	CcSEcCtD
Mefloquine—Arthralgia—Losartan—type 2 diabetes mellitus	6.25e-05	0.000552	CcSEcCtD
Mefloquine—Chest pain—Losartan—type 2 diabetes mellitus	6.25e-05	0.000552	CcSEcCtD
Mefloquine—Myalgia—Losartan—type 2 diabetes mellitus	6.25e-05	0.000552	CcSEcCtD
Mefloquine—Vomiting—Bromocriptine—type 2 diabetes mellitus	6.24e-05	0.000552	CcSEcCtD
Mefloquine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	6.24e-05	0.000552	CcSEcCtD
Mefloquine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	6.23e-05	0.000551	CcSEcCtD
Mefloquine—Anxiety—Losartan—type 2 diabetes mellitus	6.23e-05	0.00055	CcSEcCtD
Mefloquine—Tachycardia—Irbesartan—type 2 diabetes mellitus	6.21e-05	0.000549	CcSEcCtD
Mefloquine—Rash—Bromocriptine—type 2 diabetes mellitus	6.19e-05	0.000547	CcSEcCtD
Mefloquine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	6.19e-05	0.000547	CcSEcCtD
Mefloquine—Skin disorder—Irbesartan—type 2 diabetes mellitus	6.18e-05	0.000546	CcSEcCtD
Mefloquine—Discomfort—Losartan—type 2 diabetes mellitus	6.17e-05	0.000546	CcSEcCtD
Mefloquine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	6.15e-05	0.000544	CcSEcCtD
Mefloquine—Headache—Bromocriptine—type 2 diabetes mellitus	6.15e-05	0.000544	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	6.14e-05	0.000543	CcSEcCtD
Mefloquine—Diarrhoea—Glyburide—type 2 diabetes mellitus	6.14e-05	0.000543	CcSEcCtD
Mefloquine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	6.06e-05	0.000535	CcSEcCtD
Mefloquine—Paraesthesia—Metformin—type 2 diabetes mellitus	6.06e-05	0.000535	CcSEcCtD
Mefloquine—Muscle spasms—Ramipril—type 2 diabetes mellitus	6.05e-05	0.000535	CcSEcCtD
Mefloquine—Confusional state—Losartan—type 2 diabetes mellitus	6.04e-05	0.000534	CcSEcCtD
Mefloquine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	6.03e-05	0.000533	CcSEcCtD
Mefloquine—Dyspnoea—Metformin—type 2 diabetes mellitus	6.01e-05	0.000531	CcSEcCtD
Mefloquine—Somnolence—Metformin—type 2 diabetes mellitus	6e-05	0.00053	CcSEcCtD
Mefloquine—Oedema—Losartan—type 2 diabetes mellitus	5.99e-05	0.000529	CcSEcCtD
Mefloquine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	5.99e-05	0.000529	CcSEcCtD
Mefloquine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	5.98e-05	0.000529	CcSEcCtD
Mefloquine—Hypotension—Irbesartan—type 2 diabetes mellitus	5.95e-05	0.000526	CcSEcCtD
Mefloquine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	5.94e-05	0.000525	CcSEcCtD
Mefloquine—Dyspepsia—Metformin—type 2 diabetes mellitus	5.94e-05	0.000525	CcSEcCtD
Mefloquine—Tremor—Ramipril—type 2 diabetes mellitus	5.9e-05	0.000521	CcSEcCtD
Mefloquine—Shock—Losartan—type 2 diabetes mellitus	5.89e-05	0.000521	CcSEcCtD
Mefloquine—Urticaria—Valsartan—type 2 diabetes mellitus	5.88e-05	0.00052	CcSEcCtD
Mefloquine—Nervous system disorder—Losartan—type 2 diabetes mellitus	5.87e-05	0.000519	CcSEcCtD
Mefloquine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	5.86e-05	0.000518	CcSEcCtD
Mefloquine—Decreased appetite—Metformin—type 2 diabetes mellitus	5.86e-05	0.000518	CcSEcCtD
Mefloquine—Abdominal pain—Valsartan—type 2 diabetes mellitus	5.85e-05	0.000517	CcSEcCtD
Mefloquine—Tachycardia—Losartan—type 2 diabetes mellitus	5.85e-05	0.000517	CcSEcCtD
Mefloquine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	5.84e-05	0.000516	CcSEcCtD
Mefloquine—Nausea—Bromocriptine—type 2 diabetes mellitus	5.83e-05	0.000516	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	5.82e-05	0.000515	CcSEcCtD
Mefloquine—Fatigue—Metformin—type 2 diabetes mellitus	5.81e-05	0.000514	CcSEcCtD
Mefloquine—Urticaria—Orlistat—type 2 diabetes mellitus	5.81e-05	0.000514	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	5.8e-05	0.000513	CcSEcCtD
Mefloquine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	5.79e-05	0.000512	CcSEcCtD
Mefloquine—Body temperature increased—Orlistat—type 2 diabetes mellitus	5.78e-05	0.000511	CcSEcCtD
Mefloquine—Abdominal pain—Orlistat—type 2 diabetes mellitus	5.78e-05	0.000511	CcSEcCtD
Mefloquine—Asthenia—Gliclazide—type 2 diabetes mellitus	5.78e-05	0.000511	CcSEcCtD
Mefloquine—Agitation—Ramipril—type 2 diabetes mellitus	5.78e-05	0.000511	CcSEcCtD
Mefloquine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	5.71e-05	0.000505	CcSEcCtD
Mefloquine—Vomiting—Glyburide—type 2 diabetes mellitus	5.71e-05	0.000504	CcSEcCtD
Mefloquine—Pruritus—Gliclazide—type 2 diabetes mellitus	5.7e-05	0.000504	CcSEcCtD
Mefloquine—Malaise—Ramipril—type 2 diabetes mellitus	5.67e-05	0.000502	CcSEcCtD
Mefloquine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	5.67e-05	0.000502	CcSEcCtD
Mefloquine—Rash—Glyburide—type 2 diabetes mellitus	5.66e-05	0.0005	CcSEcCtD
Mefloquine—Somnolence—Irbesartan—type 2 diabetes mellitus	5.66e-05	0.0005	CcSEcCtD
Mefloquine—Dermatitis—Glyburide—type 2 diabetes mellitus	5.65e-05	0.0005	CcSEcCtD
Mefloquine—Vertigo—Ramipril—type 2 diabetes mellitus	5.65e-05	0.0005	CcSEcCtD
Mefloquine—Syncope—Ramipril—type 2 diabetes mellitus	5.64e-05	0.000499	CcSEcCtD
Mefloquine—Leukopenia—Ramipril—type 2 diabetes mellitus	5.63e-05	0.000498	CcSEcCtD
Mefloquine—Headache—Glyburide—type 2 diabetes mellitus	5.62e-05	0.000497	CcSEcCtD
Mefloquine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	5.6e-05	0.000495	CcSEcCtD
Mefloquine—Hypotension—Losartan—type 2 diabetes mellitus	5.6e-05	0.000495	CcSEcCtD
Mefloquine—Palpitations—Ramipril—type 2 diabetes mellitus	5.56e-05	0.000492	CcSEcCtD
Mefloquine—Feeling abnormal—Metformin—type 2 diabetes mellitus	5.56e-05	0.000491	CcSEcCtD
Mefloquine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	5.53e-05	0.000489	CcSEcCtD
Mefloquine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	5.53e-05	0.000489	CcSEcCtD
Mefloquine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	5.52e-05	0.000487	CcSEcCtD
Mefloquine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	5.51e-05	0.000487	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	5.49e-05	0.000486	CcSEcCtD
Mefloquine—Fatigue—Irbesartan—type 2 diabetes mellitus	5.49e-05	0.000485	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	5.46e-05	0.000482	CcSEcCtD
Mefloquine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	5.46e-05	0.000482	CcSEcCtD
Mefloquine—Convulsion—Ramipril—type 2 diabetes mellitus	5.45e-05	0.000482	CcSEcCtD
Mefloquine—Insomnia—Losartan—type 2 diabetes mellitus	5.42e-05	0.000479	CcSEcCtD
Mefloquine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	5.39e-05	0.000477	CcSEcCtD
Mefloquine—Paraesthesia—Losartan—type 2 diabetes mellitus	5.38e-05	0.000475	CcSEcCtD
Mefloquine—Urticaria—Metformin—type 2 diabetes mellitus	5.36e-05	0.000474	CcSEcCtD
Mefloquine—Arthralgia—Ramipril—type 2 diabetes mellitus	5.36e-05	0.000474	CcSEcCtD
Mefloquine—Myalgia—Ramipril—type 2 diabetes mellitus	5.36e-05	0.000474	CcSEcCtD
Mefloquine—Chest pain—Ramipril—type 2 diabetes mellitus	5.36e-05	0.000474	CcSEcCtD
Mefloquine—Dyspnoea—Losartan—type 2 diabetes mellitus	5.34e-05	0.000472	CcSEcCtD
Mefloquine—Anxiety—Ramipril—type 2 diabetes mellitus	5.34e-05	0.000472	CcSEcCtD
Mefloquine—Nausea—Glyburide—type 2 diabetes mellitus	5.33e-05	0.000471	CcSEcCtD
Mefloquine—Abdominal pain—Metformin—type 2 diabetes mellitus	5.33e-05	0.000471	CcSEcCtD
Mefloquine—Dizziness—Gliclazide—type 2 diabetes mellitus	5.33e-05	0.000471	CcSEcCtD
Mefloquine—Somnolence—Losartan—type 2 diabetes mellitus	5.32e-05	0.000471	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	5.32e-05	0.00047	CcSEcCtD
Mefloquine—Asthenia—Valsartan—type 2 diabetes mellitus	5.31e-05	0.00047	CcSEcCtD
Mefloquine—Discomfort—Ramipril—type 2 diabetes mellitus	5.29e-05	0.000468	CcSEcCtD
Mefloquine—Dyspepsia—Losartan—type 2 diabetes mellitus	5.27e-05	0.000466	CcSEcCtD
Mefloquine—Asthenia—Orlistat—type 2 diabetes mellitus	5.25e-05	0.000464	CcSEcCtD
Mefloquine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	5.24e-05	0.000464	CcSEcCtD
Mefloquine—Pruritus—Valsartan—type 2 diabetes mellitus	5.24e-05	0.000463	CcSEcCtD
Mefloquine—Decreased appetite—Losartan—type 2 diabetes mellitus	5.21e-05	0.00046	CcSEcCtD
Mefloquine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	5.2e-05	0.00046	CcSEcCtD
Mefloquine—Confusional state—Ramipril—type 2 diabetes mellitus	5.18e-05	0.000458	CcSEcCtD
Mefloquine—Pruritus—Orlistat—type 2 diabetes mellitus	5.18e-05	0.000458	CcSEcCtD
Mefloquine—Fatigue—Losartan—type 2 diabetes mellitus	5.16e-05	0.000456	CcSEcCtD
Mefloquine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	5.14e-05	0.000454	CcSEcCtD
Mefloquine—Oedema—Ramipril—type 2 diabetes mellitus	5.14e-05	0.000454	CcSEcCtD
Mefloquine—Vomiting—Gliclazide—type 2 diabetes mellitus	5.12e-05	0.000453	CcSEcCtD
Mefloquine—Rash—Gliclazide—type 2 diabetes mellitus	5.08e-05	0.000449	CcSEcCtD
Mefloquine—Dermatitis—Gliclazide—type 2 diabetes mellitus	5.08e-05	0.000449	CcSEcCtD
Mefloquine—Diarrhoea—Valsartan—type 2 diabetes mellitus	5.07e-05	0.000448	CcSEcCtD
Mefloquine—Urticaria—Irbesartan—type 2 diabetes mellitus	5.06e-05	0.000447	CcSEcCtD
Mefloquine—Shock—Ramipril—type 2 diabetes mellitus	5.05e-05	0.000447	CcSEcCtD
Mefloquine—Headache—Gliclazide—type 2 diabetes mellitus	5.05e-05	0.000446	CcSEcCtD
Mefloquine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	5.04e-05	0.000445	CcSEcCtD
Mefloquine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	5.03e-05	0.000445	CcSEcCtD
Mefloquine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	5.03e-05	0.000445	CcSEcCtD
Mefloquine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	5.03e-05	0.000444	CcSEcCtD
Mefloquine—Tachycardia—Ramipril—type 2 diabetes mellitus	5.01e-05	0.000443	CcSEcCtD
Mefloquine—Diarrhoea—Orlistat—type 2 diabetes mellitus	5.01e-05	0.000443	CcSEcCtD
Mefloquine—Skin disorder—Ramipril—type 2 diabetes mellitus	4.99e-05	0.000441	CcSEcCtD
Mefloquine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	4.96e-05	0.000439	CcSEcCtD
Mefloquine—Feeling abnormal—Losartan—type 2 diabetes mellitus	4.94e-05	0.000436	CcSEcCtD
Mefloquine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	4.9e-05	0.000433	CcSEcCtD
Mefloquine—Dizziness—Valsartan—type 2 diabetes mellitus	4.9e-05	0.000433	CcSEcCtD
Mefloquine—Dizziness—Orlistat—type 2 diabetes mellitus	4.84e-05	0.000428	CcSEcCtD
Mefloquine—Asthenia—Metformin—type 2 diabetes mellitus	4.84e-05	0.000428	CcSEcCtD
Mefloquine—Hypotension—Ramipril—type 2 diabetes mellitus	4.8e-05	0.000424	CcSEcCtD
Mefloquine—Nausea—Gliclazide—type 2 diabetes mellitus	4.79e-05	0.000423	CcSEcCtD
Mefloquine—Pruritus—Metformin—type 2 diabetes mellitus	4.77e-05	0.000422	CcSEcCtD
Mefloquine—Urticaria—Losartan—type 2 diabetes mellitus	4.76e-05	0.000421	CcSEcCtD
Mefloquine—Abdominal pain—Losartan—type 2 diabetes mellitus	4.73e-05	0.000419	CcSEcCtD
Mefloquine—Body temperature increased—Losartan—type 2 diabetes mellitus	4.73e-05	0.000419	CcSEcCtD
Mefloquine—Vomiting—Valsartan—type 2 diabetes mellitus	4.71e-05	0.000416	CcSEcCtD
Mefloquine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	4.69e-05	0.000414	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	4.68e-05	0.000414	CcSEcCtD
Mefloquine—Rash—Valsartan—type 2 diabetes mellitus	4.67e-05	0.000413	CcSEcCtD
Mefloquine—Dermatitis—Valsartan—type 2 diabetes mellitus	4.67e-05	0.000412	CcSEcCtD
Mefloquine—Vomiting—Orlistat—type 2 diabetes mellitus	4.65e-05	0.000411	CcSEcCtD
Mefloquine—Insomnia—Ramipril—type 2 diabetes mellitus	4.64e-05	0.000411	CcSEcCtD
Mefloquine—Headache—Valsartan—type 2 diabetes mellitus	4.64e-05	0.00041	CcSEcCtD
Mefloquine—Diarrhoea—Metformin—type 2 diabetes mellitus	4.61e-05	0.000408	CcSEcCtD
Mefloquine—Rash—Orlistat—type 2 diabetes mellitus	4.61e-05	0.000408	CcSEcCtD
Mefloquine—Paraesthesia—Ramipril—type 2 diabetes mellitus	4.61e-05	0.000408	CcSEcCtD
Mefloquine—Dermatitis—Orlistat—type 2 diabetes mellitus	4.61e-05	0.000407	CcSEcCtD
Mefloquine—Headache—Orlistat—type 2 diabetes mellitus	4.58e-05	0.000405	CcSEcCtD
Mefloquine—Dyspnoea—Ramipril—type 2 diabetes mellitus	4.58e-05	0.000405	CcSEcCtD
Mefloquine—Asthenia—Irbesartan—type 2 diabetes mellitus	4.57e-05	0.000404	CcSEcCtD
Mefloquine—Somnolence—Ramipril—type 2 diabetes mellitus	4.57e-05	0.000404	CcSEcCtD
Mefloquine—Dyspepsia—Ramipril—type 2 diabetes mellitus	4.52e-05	0.0004	CcSEcCtD
Mefloquine—Pruritus—Irbesartan—type 2 diabetes mellitus	4.5e-05	0.000398	CcSEcCtD
Mefloquine—Decreased appetite—Ramipril—type 2 diabetes mellitus	4.46e-05	0.000395	CcSEcCtD
Mefloquine—Dizziness—Metformin—type 2 diabetes mellitus	4.46e-05	0.000394	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	4.43e-05	0.000392	CcSEcCtD
Mefloquine—Fatigue—Ramipril—type 2 diabetes mellitus	4.43e-05	0.000391	CcSEcCtD
Mefloquine—Hypersensitivity—Losartan—type 2 diabetes mellitus	4.41e-05	0.00039	CcSEcCtD
Mefloquine—Nausea—Valsartan—type 2 diabetes mellitus	4.4e-05	0.000389	CcSEcCtD
Mefloquine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	4.35e-05	0.000385	CcSEcCtD
Mefloquine—Nausea—Orlistat—type 2 diabetes mellitus	4.35e-05	0.000384	CcSEcCtD
Mefloquine—Asthenia—Losartan—type 2 diabetes mellitus	4.3e-05	0.00038	CcSEcCtD
Mefloquine—Vomiting—Metformin—type 2 diabetes mellitus	4.29e-05	0.000379	CcSEcCtD
Mefloquine—Rash—Metformin—type 2 diabetes mellitus	4.25e-05	0.000376	CcSEcCtD
Mefloquine—Dermatitis—Metformin—type 2 diabetes mellitus	4.25e-05	0.000376	CcSEcCtD
Mefloquine—Pruritus—Losartan—type 2 diabetes mellitus	4.24e-05	0.000375	CcSEcCtD
Mefloquine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	4.23e-05	0.000374	CcSEcCtD
Mefloquine—Headache—Metformin—type 2 diabetes mellitus	4.22e-05	0.000373	CcSEcCtD
Mefloquine—Dizziness—Irbesartan—type 2 diabetes mellitus	4.21e-05	0.000372	CcSEcCtD
Mefloquine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	4.2e-05	0.000371	CcSEcCtD
Mefloquine—Diarrhoea—Losartan—type 2 diabetes mellitus	4.1e-05	0.000362	CcSEcCtD
Mefloquine—Urticaria—Ramipril—type 2 diabetes mellitus	4.08e-05	0.000361	CcSEcCtD
Mefloquine—Abdominal pain—Ramipril—type 2 diabetes mellitus	4.06e-05	0.000359	CcSEcCtD
Mefloquine—Body temperature increased—Ramipril—type 2 diabetes mellitus	4.06e-05	0.000359	CcSEcCtD
Mefloquine—Vomiting—Irbesartan—type 2 diabetes mellitus	4.05e-05	0.000358	CcSEcCtD
Mefloquine—Rash—Irbesartan—type 2 diabetes mellitus	4.01e-05	0.000355	CcSEcCtD
Mefloquine—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.01e-05	0.000354	CcSEcCtD
Mefloquine—Nausea—Metformin—type 2 diabetes mellitus	4.01e-05	0.000354	CcSEcCtD
Mefloquine—Headache—Irbesartan—type 2 diabetes mellitus	3.99e-05	0.000352	CcSEcCtD
Mefloquine—Dizziness—Losartan—type 2 diabetes mellitus	3.96e-05	0.00035	CcSEcCtD
Mefloquine—Vomiting—Losartan—type 2 diabetes mellitus	3.81e-05	0.000337	CcSEcCtD
Mefloquine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	3.78e-05	0.000334	CcSEcCtD
Mefloquine—Nausea—Irbesartan—type 2 diabetes mellitus	3.78e-05	0.000334	CcSEcCtD
Mefloquine—Rash—Losartan—type 2 diabetes mellitus	3.78e-05	0.000334	CcSEcCtD
Mefloquine—Dermatitis—Losartan—type 2 diabetes mellitus	3.77e-05	0.000333	CcSEcCtD
Mefloquine—Headache—Losartan—type 2 diabetes mellitus	3.75e-05	0.000332	CcSEcCtD
Mefloquine—Asthenia—Ramipril—type 2 diabetes mellitus	3.68e-05	0.000326	CcSEcCtD
Mefloquine—Pruritus—Ramipril—type 2 diabetes mellitus	3.63e-05	0.000321	CcSEcCtD
Mefloquine—Nausea—Losartan—type 2 diabetes mellitus	3.56e-05	0.000314	CcSEcCtD
Mefloquine—Diarrhoea—Ramipril—type 2 diabetes mellitus	3.51e-05	0.000311	CcSEcCtD
Mefloquine—Dizziness—Ramipril—type 2 diabetes mellitus	3.4e-05	0.0003	CcSEcCtD
Mefloquine—Vomiting—Ramipril—type 2 diabetes mellitus	3.27e-05	0.000289	CcSEcCtD
Mefloquine—Rash—Ramipril—type 2 diabetes mellitus	3.24e-05	0.000286	CcSEcCtD
Mefloquine—Dermatitis—Ramipril—type 2 diabetes mellitus	3.24e-05	0.000286	CcSEcCtD
Mefloquine—Headache—Ramipril—type 2 diabetes mellitus	3.22e-05	0.000284	CcSEcCtD
Mefloquine—Nausea—Ramipril—type 2 diabetes mellitus	3.05e-05	0.00027	CcSEcCtD
Mefloquine—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	3.01e-06	3.06e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	3.01e-06	3.06e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—AGT—type 2 diabetes mellitus	3e-06	3.05e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.99e-06	3.03e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.99e-06	3.03e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CD36—type 2 diabetes mellitus	2.97e-06	3.02e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	2.97e-06	3.02e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	2.97e-06	3.02e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	2.97e-06	3.02e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	2.97e-06	3.02e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CALM1—type 2 diabetes mellitus	2.95e-06	3e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—APOE—type 2 diabetes mellitus	2.94e-06	2.99e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PPP2CA—type 2 diabetes mellitus	2.93e-06	2.98e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	2.92e-06	2.96e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—APOA1—type 2 diabetes mellitus	2.91e-06	2.95e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.9e-06	2.95e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—MTHFR—type 2 diabetes mellitus	2.9e-06	2.95e-05	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.88e-06	2.93e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PPARA—type 2 diabetes mellitus	2.85e-06	2.89e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	2.84e-06	2.89e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—MTHFR—type 2 diabetes mellitus	2.82e-06	2.86e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.81e-06	2.86e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	2.81e-06	2.85e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PPARA—type 2 diabetes mellitus	2.76e-06	2.81e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—AGT—type 2 diabetes mellitus	2.76e-06	2.8e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	2.75e-06	2.8e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	2.75e-06	2.8e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.74e-06	2.79e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CALM1—type 2 diabetes mellitus	2.71e-06	2.76e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—APOE—type 2 diabetes mellitus	2.7e-06	2.75e-05	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.7e-06	2.74e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	2.68e-06	2.73e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—AGT—type 2 diabetes mellitus	2.68e-06	2.72e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—APOA1—type 2 diabetes mellitus	2.67e-06	2.71e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	2.64e-06	2.69e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CALM1—type 2 diabetes mellitus	2.63e-06	2.67e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—INS—type 2 diabetes mellitus	2.63e-06	2.67e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—APOE—type 2 diabetes mellitus	2.62e-06	2.67e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	2.62e-06	2.66e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—APOA1—type 2 diabetes mellitus	2.59e-06	2.63e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.59e-06	2.63e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	2.57e-06	2.61e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	2.57e-06	2.61e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PPARG—type 2 diabetes mellitus	2.56e-06	2.6e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	2.56e-06	2.6e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	2.56e-06	2.6e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	2.56e-06	2.6e-05	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.56e-06	2.6e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.54e-06	2.58e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.54e-06	2.58e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.53e-06	2.58e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.53e-06	2.57e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.52e-06	2.56e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	2.52e-06	2.56e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—INS—type 2 diabetes mellitus	2.51e-06	2.55e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	2.5e-06	2.54e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	2.5e-06	2.54e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	2.5e-06	2.54e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	2.49e-06	2.53e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	2.47e-06	2.51e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	2.45e-06	2.49e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	2.45e-06	2.49e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	2.44e-06	2.48e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	2.42e-06	2.46e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	2.42e-06	2.46e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.41e-06	2.45e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	2.41e-06	2.45e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.4e-06	2.43e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	2.37e-06	2.41e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.37e-06	2.41e-05	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	2.37e-06	2.41e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	2.36e-06	2.4e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	2.36e-06	2.4e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	2.36e-06	2.4e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	2.36e-06	2.4e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	2.36e-06	2.4e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PPARG—type 2 diabetes mellitus	2.35e-06	2.39e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	2.34e-06	2.38e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.32e-06	2.36e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	2.32e-06	2.36e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—INS—type 2 diabetes mellitus	2.31e-06	2.35e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.31e-06	2.34e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.31e-06	2.34e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—ALB—type 2 diabetes mellitus	2.3e-06	2.34e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	2.3e-06	2.34e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PPARG—type 2 diabetes mellitus	2.28e-06	2.32e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	2.28e-06	2.32e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	2.28e-06	2.32e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	2.28e-06	2.32e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	2.27e-06	2.31e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	2.24e-06	2.28e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	2.24e-06	2.28e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	2.24e-06	2.28e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—INS—type 2 diabetes mellitus	2.24e-06	2.28e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.21e-06	2.24e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	2.2e-06	2.24e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—NOS3—type 2 diabetes mellitus	2.2e-06	2.24e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PIK3R1—type 2 diabetes mellitus	2.2e-06	2.24e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	2.18e-06	2.22e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	2.17e-06	2.21e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.15e-06	2.19e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	2.14e-06	2.18e-05	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.14e-06	2.17e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	2.14e-06	2.17e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—ALB—type 2 diabetes mellitus	2.12e-06	2.15e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	2.11e-06	2.15e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	2.11e-06	2.15e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	2.11e-06	2.15e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	2.07e-06	2.11e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	2.06e-06	2.09e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—ALB—type 2 diabetes mellitus	2.05e-06	2.09e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	2.05e-06	2.09e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	2.03e-06	2.06e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	2.03e-06	2.06e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.02e-06	2.06e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—NOS3—type 2 diabetes mellitus	2.02e-06	2.06e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PTGS2—type 2 diabetes mellitus	2.01e-06	2.05e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	2.01e-06	2.05e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	2.01e-06	2.04e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.98e-06	2.01e-05	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.98e-06	2.01e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.97e-06	2.01e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PIK3R1—type 2 diabetes mellitus	1.96e-06	2e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—NOS3—type 2 diabetes mellitus	1.96e-06	2e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.96e-06	1.99e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	1.94e-06	1.98e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.94e-06	1.98e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.94e-06	1.98e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	1.94e-06	1.97e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	1.94e-06	1.97e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	1.94e-06	1.97e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	1.94e-06	1.97e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.94e-06	1.97e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	1.93e-06	1.97e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	1.91e-06	1.94e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	1.91e-06	1.94e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	1.86e-06	1.89e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	1.86e-06	1.89e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PTGS2—type 2 diabetes mellitus	1.85e-06	1.88e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.85e-06	1.88e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	1.83e-06	1.86e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	1.83e-06	1.86e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.83e-06	1.86e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PTGS2—type 2 diabetes mellitus	1.8e-06	1.83e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.79e-06	1.82e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	1.73e-06	1.76e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.71e-06	1.73e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	1.68e-06	1.7e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.68e-06	1.7e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	1.67e-06	1.7e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.66e-06	1.69e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	1.65e-06	1.67e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	1.61e-06	1.64e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	1.6e-06	1.62e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	1.58e-06	1.61e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	1.58e-06	1.61e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	1.58e-06	1.61e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.58e-06	1.61e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	1.57e-06	1.6e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	1.55e-06	1.58e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	1.55e-06	1.58e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	1.55e-06	1.58e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	1.54e-06	1.57e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	1.54e-06	1.57e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	1.54e-06	1.57e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	1.53e-06	1.56e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	1.53e-06	1.55e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.52e-06	1.55e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	1.51e-06	1.53e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	1.5e-06	1.53e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.49e-06	1.52e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	1.49e-06	1.52e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	1.49e-06	1.51e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.49e-06	1.51e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	1.49e-06	1.51e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	1.47e-06	1.49e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	1.45e-06	1.47e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	1.44e-06	1.46e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.43e-06	1.46e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	1.41e-06	1.43e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	1.4e-06	1.43e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	1.38e-06	1.4e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	1.38e-06	1.4e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	1.38e-06	1.4e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	1.37e-06	1.4e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.37e-06	1.4e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	1.37e-06	1.39e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	1.36e-06	1.38e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	1.35e-06	1.37e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	1.35e-06	1.37e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	1.34e-06	1.37e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.32e-06	1.34e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	1.31e-06	1.33e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	1.29e-06	1.32e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	1.28e-06	1.3e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	1.28e-06	1.3e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	1.27e-06	1.29e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	1.26e-06	1.29e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.26e-06	1.28e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.25e-06	1.27e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.25e-06	1.27e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.23e-06	1.25e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.21e-06	1.23e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.21e-06	1.23e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.2e-06	1.22e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.2e-06	1.22e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.19e-06	1.21e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.15e-06	1.17e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	1.11e-06	1.13e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—INS—type 2 diabetes mellitus	1.09e-06	1.11e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.06e-06	1.08e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.05e-06	1.07e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.03e-06	1.05e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.03e-06	1.05e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.03e-06	1.05e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.03e-06	1.05e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.01e-06	1.03e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—AKT1—type 2 diabetes mellitus	1.01e-06	1.03e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	1e-06	1.02e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	9.85e-07	1e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	9.58e-07	9.74e-06	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	9.58e-07	9.74e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	9.58e-07	9.74e-06	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	9.44e-07	9.6e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	9.4e-07	9.56e-06	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—AKT1—type 2 diabetes mellitus	9.3e-07	9.45e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	9.21e-07	9.36e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	9.17e-07	9.32e-06	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	9.03e-07	9.18e-06	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	9.03e-07	9.18e-06	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—AKT1—type 2 diabetes mellitus	9.03e-07	9.18e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	8.93e-07	9.08e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	8.82e-07	8.97e-06	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	8.77e-07	8.91e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	8.47e-07	8.61e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	8.31e-07	8.44e-06	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	8.26e-07	8.4e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	8.04e-07	8.18e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	7.91e-07	8.04e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	7.88e-07	8.01e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	7.79e-07	7.92e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	6.87e-07	6.98e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	6.73e-07	6.84e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	6.17e-07	6.27e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	5.9e-07	6e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	5.9e-07	6e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	5.4e-07	5.49e-06	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	4.41e-07	4.48e-06	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	4.15e-07	4.22e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	2.71e-07	2.76e-06	CbGpPWpGaD
